Skip to content

A Study of a Sea-Derived Skin Care Product to Improve the Appearance of Facial Fine Lines and Wrinkles in Adults

A Prospective, Open-Label, Single-Arm clinical study to evaluate the safety and efficacy of marine spicule-based skin care formulation in adults with mild-to-moderate facial fine lines and wrinkles - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109862
Enrollment
40
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Marine spicule-based formulation: Topical application of Marine spicule-based skin care formulation Total duration of study is 3 months Control Intervention1: NOT APPLICABLE: NOT APPLIC

Sponsors

Dr Madhuri T J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of mild-to-moderate facial fine lines and wrinkles in the prespecified target area 2. Visible mild-to-moderate reduction in facial skin smoothness/texture in the target area, suitable for clinical grading 3. Healthy intact facial skin in the assessment area

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation 2. Severe facial wrinkles or severe photodamage unsuitable for topical cosmetic evaluation 3. Active facial dermatosis, including eczema, dermatitis, psoriasis, active infection, or inflammatory acne in the target area 4. Open wounds, abrasions, sunburn, or broken skin on the face 5. Known hypersensitivity to any component of the study products 6. Significant uncontrolled systemic illness or medical condition that may interfere with study participation 7. Use of topical anti-aging actives, prescription facial products, or medicated cosmetic products on the face within 2 weeks before baseline 8. Chemical peels, facials, microdermabrasion, or similar resurfacing procedures within 4 weeks 9. Botulinum toxin, fillers, microneedling, laser, threads, or energy-based facial procedures within 6 months 10. Participation in another clinical study within the previous 30 days 11. Any other condition that, in the investigator s opinion, makes the participant` unsuitable

Design outcomes

Primary

MeasureTime frame
Wrinkle grading scale will be used to evaluate: Crow s Feet Forehead LinesTimepoint: Baseline Day 0, Day 14, Day 28.

Secondary

MeasureTime frame
Change in facial skin roughness, texture, and coarseness from baseline to Day 28 Assessment will be done using the Allergan Skin Roughness Scale ASRS.Timepoint: Baseline Day 0, Day 14, Day 28;Investigator assessed overall aesthetic improvement Assessment will be done using the Investigator Global Aesthetic Improvement Scale GAIS.Timepoint: Day 14 and Day 28;Participant perceived improvement in facial skin quality Assessment will be done using a Subject Self Assessment Questionnaire evaluating perceived changes in fine lines and wrinkles, smoothness, softness, hydration, firmness or tightness, and overall skin appearance.Timepoint: Day 14 and Day 28;Standardized photographs will be taken and compared across visits to document visible changes in facial fine lines, wrinkles, texture, and overall appearance.Timepoint: Baseline Day 0, Day 14, Day 28;Safety and tolerability will be assessed by recording local skin reactions including erythema, dryness, scaling, burning or stinging, itching, and any other local cutaneous reaction.Timepoint: Baseline Day 0, Day 14, Day 28

Countries

India

Contacts

Public ContactMs Kartiki Wani

The Esthetic Clinics (TEC )

varad.saptarshi@theestheticclinics.com9136673922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026